Aura Biosciences Obtains $21,000,000 Series B Financing

  • Feed Type
  • Date
    3/5/2015
  • Company Name
    Aura Biosciences
  • Mailing Address
    85 Bolton Street Cambridge, MA 02140 USA
  • Company Description
    Aura Biosciences is a next generation biotech company – combining the expertise of leading academic institutions through research and licensing agreements, with the flexibility and efficiency of a dedicated team of in-house scientists, deal-makers, and world class advisors.
  • Website
    http://www.aurabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will be used to advance Aura’s unique and novel therapies into clinical trials for the treatment of rare cancers of the eye, and to further develop for additional cancer indications its first-in-class technology that was discovered and developed in partnership with Dr. John Schiller at the National Cancer Institute (NCI).
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy